Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

Alan Menter, Bruce E. Strober, Daniel H. Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. LeonardiJason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena N. Rupani, Michael Siegel, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan*, Craig A. Elmets

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

214 Scopus citations

Abstract

Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.

Original languageEnglish (US)
Pages (from-to)1029-1072
Number of pages44
JournalJournal of the American Academy of Dermatology
Volume80
Issue number4
DOIs
StatePublished - Apr 2019

Keywords

  • biologic agents
  • clinical guidelines for psoriasis
  • dermatology
  • guidelines
  • monoclonal antibodies
  • psoriasis
  • skin disease

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics'. Together they form a unique fingerprint.

Cite this